Englander Institute for Precision Medicine
Found 920 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2026
Abrahimi P, Khan JF, Duren-Lubanski A, Cai W, Marouf Y, Chen N, Hirschhorn D, Mammone R, Miranda IC, Tallman JE et al..  2026.  Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.. J Exp Med. 223(7)
Bleve S, Ravera F, Rodrigues S, Pederzoli F, Pakula H, Brighi N, Giunta EFrancesco, Schepisi G, Virga A, Gurioli G et al..  2026.  Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.. Prostate Cancer Prostatic Dis.
Chaudhry F, Kim TWan, Elemento O, Betel D.  2026.  Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson's disease.. Front Aging Neurosci. 18:1730550.
Oro AE, Amagai M, Payne AS, Ellebrecht C, Hovnanian A, Anandasabapathy N, Leachman SA, Harris-Tryon T.  2026.  Mechanistic insights into emerging therapeutic platforms: The 72nd annual Montagna Symposium on the biology of skin.. J Invest Dermatol.
Anwardeen N, Razzaq A, Elashi AA, Thareja G, Diboun I, Naja K, Suhre K, Elrayess MA.  2026.  Metformin Treatment Potentially Modifies Genetically Driven Metabolite-HbA1c Associations: A Gene-Environment Interaction Mendelian Randomization Study.. Pharmaceuticals (Basel). 19(5)
Grimont A, Falvo DJ, Sisso WJ, Santos F, Chan CW, Zumbo P, Fall WB, Ferrick K, Pan G, Cleveland M et al..  2026.  Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis.. Dev Cell.
Likasitwatanakul P, Blinka SM, Zarka JG, Gebrael G, Weg E, Longoria O, Moore JA, Sharp A, de Bono J, Sternberg CN et al..  2026.  Molecular landscape of prostate cancers with clival metastases.. Oncologist. 31(4)
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(2):465-480.
Koprulu M, Smith-Byrne K, Ferolito BRichard, Macdonald-Dunlop E, Luan J'an, Hedman ÅK, Ogamba CFranklin, Kuliesius J, Repetto L, Ramisch A et al..  2026.  Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.. Cell. 189(11):3339-3357.e11.
Elemento O.  2026.  Multi-Hospital Electronic Health Record Foundation Models Without Data Sharing: A Comparison of Federated Learning and Inference-Time Ensembling.. medRxiv.
Surapaneni S, Kutler RB, Setzen SA, Kim YEun, Yao P, Siddiqui SH, Pitman MJ, Sulica L, Elemento O, Khosravi P et al..  2026.  A Multimodal Approach for Deep-Learning Classification of Vocal Fold Pathologies in Stroboscopy.. Laryngoscope.
Xu C, Us I, Cohen-Setton J, Milo M, Sidders B, Fitzgibbon J, Melnick AM, Pan H, Bulusu KC, Elemento O.  2026.  PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.. Res Sq.
Kuo H-H, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, Guevara D, Otilano J, Moyer J, Tranquille M et al..  2026.  Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.. Sci Adv. 12(26):eadz3351.
Xing Y, Reznikov I, Ahmed ANur, Sidhu I, Wisnewski J, Farhat A, Prystupa A, Konieczny P, Mansfield K, Cooper ML et al..  2026.  Peripheral immune-inducer dendritic cells drive early-life allergic inflammation.. Nature.
De Boni L, Claridge S, Nath S, Tofani K, Stein BD, Park E, Steiner S, Elemento O, Pauli C, Hopkins BD.  2026.  Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors.. iScience. 29(3):114954.
Tignor NL, Koptyra M, Chowdhury S, Petralia F, Gritsenko MA, Ma W, Zhu Y, Marino GB, Song X, Migliozzi S et al..  2026.  Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets.. Cell Rep Med. :103024.
Toth R, Choi S, Le Naour-Vernet M, Schwanke F, Johnson JL, Tee EE, Yaron-Barir TM, Khochaba E, Derbyshire P, Colo A et al..  2026.  Publisher Correction: Motif-based substrate mapping of the receptor-like cytoplasmic kinase BIK1 reveals novel components and regulatory nodes of plant immunity.. Nat Plants. 12(3):666.
Du W, De Boni L, Hopkins BDavid, Elemento O.  2026.  A quantitative approach for defining the degradability landscape of protein degraders.. Nat Commun.
Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, Rosales M, Haas GP, Saad F, Hussain M et al..  2026.  Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2402829.
Duren-Lubanski A, Podaza E, Merrit E, Tocheva AS, M Martin L, Elemento O, Hopkins BD.  2026.  A Real-Time Image-Based Co-Culture Assay to Quantify Tumor-Infiltrating Lymphocyte-Mediated Apoptotic Killing of Patient-Derived Tumor Organoids.. J Vis Exp. (235)
Al-Thani NM, Toor SM, Umlai U-KIsmail, Aliyu U, Suhre K, Albagha OME.  2026.  Refining the Genetic Contribution to Type 2 Diabetes Subtypes.. Diabetes Obes Metab.
Armstrong AJ, Azad AA, Saad F, Hussain M, Iguchi T, Stenzl A, Sternberg CN.  2026.  Reply to: Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide.. J Clin Oncol. :JCO2601500.
Hanif SZ, Kutz C, Au CMCherie, Torregroza I, Palikhe S, Jannath SY, Fabiha T, Bhinder B, Washburn MP, Devost D et al..  2026.  Role of orphan G protein-coupled receptor GPR52 in breast cancer cell multicellular organization and collective invasion.. Br J Cancer.
Maushagen J, Grune E, Schlett CL, Kiefer LSophie, Suhre K, Adamski J, Wang-Sattler R, Peters A, Bamberg F, Rospleszcz S.  2026.  Serum metabolite patterns of adipose tissue distribution and body composition subphenotypes.. Lipids Health Dis. 25(1)
Belkadi A, Thareja G, Stephan N, Halama A, Suhre K.  2026.  Size-Resolved Lipoprotein Fatty Acid Content as a Novel Nuclear Magnetic Resonance-Derived Trait Specifically Associates with Genetic Variants That Control Fatty Acid Metabolism.. J Proteome Res.